Investigators developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the disease and better identify therapies that are most likely to work for each individual patient. By using 3D mini tumor models that closely resemble a patient’s tumor, treatments could be tailored more effectively, paving the way for more personalized cancer treatments.
Geigermeter News Magazine